[Three-year observation of permanent neonatal diabetes]

Anna Noczyńska1, Agnieszka Zubkiewicz-Kucharska, Barbara Salmonowicz

  • 1Katedra i Klinika Endokrynologii i Diabetologii Wsieku Rozwojowego Akademii Medycznej, Wroclaw. anocz@endo.am.wroc.pl

Insights

This study observed children with neonatal diabetes due to KCNJ11 and ABCC8 gene mutations. Sulfonylurea treatment effectively managed blood sugar, though dose reductions were needed.

Area of Science:

  • Pediatric Endocrinology
  • Molecular Genetics

Background:

  • Neonatal diabetes mellitus (NDM) is a rare condition often caused by genetic mutations.
  • Permanent NDM can result from activating mutations in KCNJ11 (Kir6.2) and ABCC8 (SUR1) genes.

Observation:

  • A three-year follow-up of four children with permanent NDM due to heterozygous KCNJ11/ABCC8 mutations.
  • Three patients experienced developmental delay alongside their diabetes.
  • Glucagon tests indicated normal c-peptide secretion in all participants.

Findings:

  • Treatment with sulfonylureas (SU) maintained glycemic control (HbA1c <7%) in all patients.
  • All children required a reduction in their SU dosage over the observation period.

Implications:

  • KCNJ11 and ABCC8 mutations are significant causes of permanent neonatal diabetes.
  • Sulfonylureas are an effective treatment for this NDM subtype.
  • Long-term management may necessitate SU dose adjustments and monitoring for developmental outcomes.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...